Ansbach, Germany

Michael Lippert

USPTO Granted Patents = 21 

 

Average Co-Inventor Count = 2.7

ph-index = 8

Forward Citations = 1,145(Granted Patents)


Company Filing History:


Years Active: 2002-2016

Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Michael Lippert

Introduction

Michael Lippert, based in Ansbach, Germany, is a prominent inventor known for his groundbreaking work in the field of medical devices. With an impressive portfolio of 21 patents, Lippert has significantly advanced the technological capabilities of healthcare solutions.

Latest Patents

Two of his most notable recent patents include an implantable medical device and a heart monitor. The implantable medical device features an integrated or connectable implantable three-dimensional acceleration sensor, paired with a ballistocardiogram (BCG) capturing unit. This innovative device processes signals from the sensor to evaluate heart function accurately. The heart monitor further enhances cardiac assessments by incorporating a preload determination unit that provides critical data on heart performance through detailed evaluations of contractility and preload values.

Career Highlights

Michael Lippert has made significant contributions through his roles at Biotronik CRM Patent AG and Biotronik SE & Co. KG. His work at these companies has been instrumental in developing advanced medical technologies that improve patient outcomes.

Collaborations

Throughout his career, Lippert has collaborated with talented professionals such as Gerald Czygan and Olaf Skerl. These partnerships have played a vital role in fostering innovation and driving forward the development of new medical solutions.

Conclusion

Michael Lippert's dedication to innovation in medical technology is evidenced by his extensive patent portfolio and the impactful solutions he has developed. His contributions not only reflect his engineering acumen but also his commitment to enhancing healthcare technologies that serve patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…